132 related articles for article (PubMed ID: 8141838)
1. Effect of lovastatin on the secretion of very low density lipoprotein lipids and apolipoprotein B in the hypertriglyceridemic Zucker obese rat.
Kasim SE; Elovson J; Khilnani S; Almario RU; Jen KL
Atherosclerosis; 1993 Dec; 104(1-2):147-52. PubMed ID: 8141838
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of triglyceride-lowering effect of an HMG-CoA reductase inhibitor in a hypertriglyceridemic animal model, the Zucker obese rat.
Kasim SE; LeBoeuf RC; Khilnani S; Tallapaka L; Dayananda D; Jen KL
J Lipid Res; 1992 Jan; 33(1):1-7. PubMed ID: 1552226
[TBL] [Abstract][Full Text] [Related]
3. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
4. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models.
Krause BR; Newton RS
Atherosclerosis; 1995 Oct; 117(2):237-44. PubMed ID: 8801869
[TBL] [Abstract][Full Text] [Related]
5. Fluvastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, suppresses very low-density lipoprotein secretion in puromycin aminonucleoside-nephrotic rats.
Moritomo Y; Hirano T; Ebara T; Kurokawa M; Naito H; Furukawa S; Nagano S
Nephron; 1994; 67(2):218-25. PubMed ID: 8072613
[TBL] [Abstract][Full Text] [Related]
6. Physiologic mechanisms of action of lovastatin in nephrotic syndrome.
Aguilar-Salinas CA; Barrett PH; Kelber J; Delmez J; Schonfeld G
J Lipid Res; 1995 Jan; 36(1):188-99. PubMed ID: 7706943
[TBL] [Abstract][Full Text] [Related]
7. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
[TBL] [Abstract][Full Text] [Related]
8. Regulation of low density lipoprotein apoprotein B metabolism by lovastatin and cholestyramine in miniature pigs: effects on LDL composition and synthesis of LDL subfractions.
Huff MW; Telford DE
Metabolism; 1989 Mar; 38(3):256-64. PubMed ID: 2918845
[TBL] [Abstract][Full Text] [Related]
9. Pravastatin sodium, a competitive inhibitor of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreases the cholesterol content of newly secreted very-low-density lipoprotein in Watanabe heritable hyperlipidemic rabbits.
Shiomi M; Ito T
Metabolism; 1994 May; 43(5):559-64. PubMed ID: 8177044
[TBL] [Abstract][Full Text] [Related]
10. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
[TBL] [Abstract][Full Text] [Related]
11. Lovastatin therapy in familial dysbetalipoproteinemia: effects on kinetics of apolipoprotein B.
Vega GL; East C; Grundy SM
Atherosclerosis; 1988 Mar; 70(1-2):131-43. PubMed ID: 3162680
[TBL] [Abstract][Full Text] [Related]
12. Effect of pravastatin sodium, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on very-low-density lipoprotein composition and kinetics in hyperlipidemia associated with experimental nephrosis.
Hirano T; Komuro F; Furukawa S; Nagano S; Takahashi T
Metabolism; 1990 Jun; 39(6):605-9. PubMed ID: 2112675
[TBL] [Abstract][Full Text] [Related]
13. Dietary fish oil plus lovastatin decreases both VLDL and LDL apo B production in miniature pigs.
Huff MW; Telford DE; Barrett PH
Arterioscler Thromb; 1992 Aug; 12(8):902-10. PubMed ID: 1637788
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
Ginsberg HN; Le NA; Gibson JC
J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of hypertriglyceridemia in the coconut oil/cholesterol-fed rabbit. Increased secretion and decreased catabolism of very low density lipoprotein.
Van Heek M; Zilversmit DB
Arterioscler Thromb; 1991; 11(4):918-27. PubMed ID: 2065043
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications.
Watts GF; Cummings MH; Umpleby M; Quiney JR; Naoumova R; Thompson GR; Sönksen PH
Eur J Clin Invest; 1995 Aug; 25(8):559-67. PubMed ID: 7589011
[TBL] [Abstract][Full Text] [Related]
17. Effect of removal of lipoproteins of different composition on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and hepatic very low density lipoprotein secretion.
Van Zuiden PE; Erickson SK; Cooper AD
J Lipid Res; 1983 Apr; 24(4):418-28. PubMed ID: 6854151
[TBL] [Abstract][Full Text] [Related]
18. Effects of lovastatin on the levels, structure, and atherogenicity of VLDL in patients with moderate hypertriglyceridemia.
Gianturco SH; Bradley WA; Nozaki S; Vega GL; Grundy SM
Arterioscler Thromb; 1993 Apr; 13(4):472-81. PubMed ID: 8385478
[TBL] [Abstract][Full Text] [Related]
19. Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteins.
Arad Y; Ramakrishnan R; Ginsberg HN
Metabolism; 1992 May; 41(5):487-93. PubMed ID: 1588827
[TBL] [Abstract][Full Text] [Related]
20. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
